BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1299 related articles for article (PubMed ID: 23676191)

  • 41. Stent-grafts are the best way to treat complex in-stent restenosis lesions in the superficial femoral artery: 24-month results from a multicenter randomized trial.
    Bosiers M; Deloose K; Callaert J; Verbist J; Hendriks J; Lauwers P; Schroë H; Lansink W; Scheinert D; Schmidt A; Zeller T; Beschorner U; Noory E; Torsello G; Austermann M; Wauters J
    J Cardiovasc Surg (Torino); 2020 Oct; 61(5):617-625. PubMed ID: 33231029
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Edge Stenosis After Covered Stenting for Long Superficial Femoral Artery Occlusive Disease: Risk Factor Analysis and Prevention With Drug-Coated Balloon Angioplasty.
    Lin TC; Huang CY; Chen PL; Lee CY; Shih CC; Chen IM
    J Endovasc Ther; 2018 Jun; 25(3):313-319. PubMed ID: 29673299
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Five-year outcomes of self-expanding nitinol stent implantation for chronic total occlusion of the superficial femoral and proximal popliteal artery.
    Sakamoto Y; Hirano K; Iida O; Soga Y; Suzuki K; Muramatsu T; Tsukahara R
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E251-6. PubMed ID: 23536429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease.
    Saxon RR; Dake MD; Volgelzang RL; Katzen BT; Becker GJ
    J Vasc Interv Radiol; 2008 Jun; 19(6):823-32. PubMed ID: 18503895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A hybrid approach to recanalization of a chronic iliofemoral occlusion.
    Ahanchi SS; Panneton JM; Stout CL
    J Vasc Surg; 2013 Jan; 57(1):230-3. PubMed ID: 22963813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Timing of the restenosis following nitinol stenting in the superficial femoral artery and the factors associated with early and late restenoses.
    Iida O; Uematsu M; Soga Y; Hirano K; Suzuki K; Yokoi H; Muramatsu T; Inoue N; Nanto S; Nagata S
    Catheter Cardiovasc Interv; 2011 Oct; 78(4):611-7. PubMed ID: 21805562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stent-Graft Length Is Associated with Decreased Patency in Treatment of Central Venous Stenosis in Hemodialysis Patients.
    Boutrous ML; Alvarez AC; Okoye OT; Laws JC; Jacobs DL; Smeds MR
    Ann Vasc Surg; 2019 Aug; 59():225-230. PubMed ID: 31009722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial.
    Duda SH; Bosiers M; Lammer J; Scheinert D; Zeller T; Oliva V; Tielbeek A; Anderson J; Wiesinger B; Tepe G; Lansky A; Jaff MR; Mudde C; Tielemans H; Beregi JP
    J Endovasc Ther; 2006 Dec; 13(6):701-10. PubMed ID: 17154704
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trial.
    Bosiers M; Deloose K; Callaert J; Verbist J; Hendriks J; Lauwers P; Schroë H; Lansink W; Scheinert D; Schmidt A; Zeller T; Beschorner U; Noory E; Torsello G; Austermann M; Peeters P
    J Endovasc Ther; 2015 Feb; 22(1):1-10. PubMed ID: 25775672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery.
    Soga Y; Iida O; Hirano K; Suzuki K; Tosaka A; Yokoi H; Nobuyoshi M
    J Vasc Surg; 2011 Oct; 54(4):1058-66. PubMed ID: 21880459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of the Viabahn stent graft for the treatment of recurrent cephalic arch stenosis in hemodialysis accesses.
    Miller GA; Preddie DC; Savransky Y; Spergel LM
    J Vasc Surg; 2018 Feb; 67(2):522-528. PubMed ID: 28947227
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retrospective Multicenter Comparison Between Viabahn Covered Stent-Grafts and Supera Interwoven Nitinol Stents for Endovascular Treatment in Severely Calcified Femoropopliteal Artery Disease: The ARMADILLO Study (Adjusted Retrospective coMparison of scAffolDs In caLcified LesiOns).
    Horie K; Takahara M; Nakama T; Tanaka A; Tobita K; Hayakawa N; Mori S; Iwata Y; Suzuki K
    J Endovasc Ther; 2024 Jun; 31(3):400-409. PubMed ID: 36146948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stent graft treatment for infra-inguinal arterial disease for either instent-restenosis and denovo lesions associated with very high rates of failure.
    Golla MS; Acharji S; Paul TK; Madapathi P; Garcia LA
    Catheter Cardiovasc Interv; 2018 May; 91(6):1130-1135. PubMed ID: 29214713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Real-World Experience With the Supera Interwoven Nitinol Stent in Femoropopliteal Arteries: Midterm Patency Results and Failure Analysis.
    Myint M; Schouten O; Bourke V; Thomas SD; Lennox AF; Varcoe RL
    J Endovasc Ther; 2016 Jun; 23(3):433-41. PubMed ID: 27004494
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The outcome of failed endografts inserted for superficial femoral artery occlusive disease.
    Lensvelt MM; Golchehr B; Kruse RR; Holewijn S; van Walraven LA; Fritschy WM; Zeebregts CJ; Reijnen MM
    J Vasc Surg; 2013 Feb; 57(2):415-20. PubMed ID: 23159477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary stenting of the superficial femoral and popliteal artery.
    Dearing DD; Patel KR; Compoginis JM; Kamel MA; Weaver FA; Katz SG
    J Vasc Surg; 2009 Sep; 50(3):542-7. PubMed ID: 19540706
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Results of the Protégé EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions.
    Bosiers M; Deloose K; Callaert J; Moreels N; Keirse K; Verbist J; Peeters P
    J Vasc Surg; 2011 Oct; 54(4):1042-50. PubMed ID: 21636239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease.
    Dosluoglu HH; Cherr GS; Lall P; Harris LM; Dryjski ML
    J Vasc Surg; 2008 Nov; 48(5):1166-74. PubMed ID: 18692357
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-Term Outcomes of Self-Expandable Nitinol Stent Implantation With Intraluminal Angioplasty to Treat Chronic Total Occlusion in the Superficial Femoral Artery (TransAtlantic Inter-Society Consensus Type D Lesions).
    Matsumi J; Ochiai T; Tobita K; Shishido K; Sugitatsu K; Mizuno S; Yamanaka F; Murakami M; Tanaka Y; Takahashi S; Akasaka T; Saito S
    J Invasive Cardiol; 2016 Feb; 28(2):58-64. PubMed ID: 26841438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ten years' experience in endovascular repair of popliteal artery aneurysm using the Viabahn endoprosthesis: a report from two Italian vascular centers.
    Speziale F; Sirignano P; Menna D; Capoccia L; Mansour W; Serrao E; Ronchey S; Alberti V; Esposito A; Mangialardi N
    Ann Vasc Surg; 2015 Jul; 29(5):941-9. PubMed ID: 25757986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.